Committed to health for more than 75 years

We consolidate our presence in Slovenia through continuous investment in development and production capacity. We build a stimulating, competitive and supportive work environment. We strengthen our role as a catalyst for the development of the pharmaceutical industry in Slovenia.

Read key business and development news in our company and various activities that we support and co-create. You can also browse the news archives dating back to 1998, our photo library and visual identity. For additional information, you can write to us at info.lek@sandoz.com.

Press releases
29. 9. 2022

Once again and for the third time in a row, Lek has been chosen as the most reputable employer in Slovenia according to the ...

29. 9. 2022

In September, our organization joined the network of dementia-friendly institutions, with all four of our sites (Ljubljana, Mengeš, Prevalje, and Lendava) becoming dementia-friendly spots. We ...

27. 9. 2022

Lek, a part of Novartis, was awarded the 2021 Good Practice Award for employing disabled people by the Ministry of Labor, Family, Social Affairs, and ...

22. 9. 2022

Chronic myeloid leukemia (CML) is a type of blood cancer.

Contact

Lek d.d.
Verovškova 57, 1526 Ljubljana, Slovenia
T: +386 1 580 21 11
F: +386 1 568 35 17
info.lek@sandoz.com
VAT No.: SI87916452
Registration number: 1732811000
Nominal capital: 48.402.003,00 EUR

Video library